Familial Adenomatous Polyposis (FAP) is a hereditary condition that results in the early development of polyps and colorectal cancer that could starts at the early age of 12 years old. FAP is considered as an orphan disease, with a prevalence of 0,6/1,0 out of 10.000. Caused by germline mutations in the APC gene it is characterized by the development of hundreds to thousands of polyps and carriers of the APC gene mutation, if not treated appropriately, will develop colorectal cancer. Unfortunately at the moment there is no safe treatment available.
Leader in Pharmaceutical Omega 3 Manufacturing
Leader in Pharmaceutical Omega 3 Manufacturing
시장보고서]가족성 선종성 용종증(FAP) : 개발중인 약제(2021년)
Daniele Polettini on LinkedIn: KD Pharma CDMO Division
Leader in Pharmaceutical Omega 3 Manufacturing
Pharma omega-3s: Beyond the surface
KD Pharma Group - Crunchbase Company Profile & Funding
KD Pharma Group has the largest lipids extraction technology portfolio
Fapon Biotech Inc.
KD Pharma Group - capiton
Leader in Pharmaceutical Omega 3 Manufacturing
Promising fish oil-based coronavirus treatment heads to clinical
KD Pharma Group - capiton
